Aman Patel joined ICR Westwicke in 2021 as a Managing Director. Aman has worked in healthcare equity research for almost two decades, including experience on both the buy-side and sell-side.
Most recently, he has acted as an independent consultant to healthcare companies on investor relations and corporate strategy matters.
Previously, Aman worked for Systematic Financial Management (AMG) for 17 years, beginning as a research analyst and ultimately as a portfolio manager of a multi-billion dollar long-only fund. Aman began his career on the sell-side working at UBS and Prudential Securities covering medical devices and biotechnology, respectively. His coverage included Celgene, Biogen, Gilead Sciences, Boston Scientific, Medtronic, and Zimmer among others.
At ICR Westwicke, Aman is focused on advising companies in the healthcare industry, concentrating his efforts in the medical technology/diagnostics and life sciences sectors. As a senior member of the team, Aman actively engages with both private and public clients in capital markets advisory and strategic investor relations, leveraging his strong relationships in the sector and investment expertise.
Aman received an MBA in Finance from Carnegie Mellon University and a BA in Molecular Biology from Rutgers University. He is also a CFA charterholder. Aman lives in New Jersey with his wife and three children.